Simcere Pharmaceutical Group Limited (HK:2096) has released an update.
Simcere Pharmaceutical Group Limited has announced the approval of their hypnotic drug, Daridorexant hydrochloride tablets, by the Pharmacy and Poisons Board of Hong Kong. The medication, developed in partnership with Idorsia Pharmaceuticals Ltd., is designed to assist sleep without altering sleep architecture and has been well-received in international clinical studies. This new approval follows the drug’s previous authorizations in several countries and marks a significant milestone for Simcere’s expansion in the Greater China region.
For further insights into HK:2096 stock, check out TipRanks’ Stock Analysis page.
